How Chiropractors Can Use CGM Data to Understand the Metabolic Drivers of Musculoskeletal Pain

Chiropractic practice has always been grounded in the understanding that the nervous system and musculoskeletal system are not isolated from the rest of the body. A chiropractor treating a patient for chronic low back pain knows that recovery is affected by sleep quality, stress levels, inflammation, and systemic health in ways that go beyond the structural and mechanical. Continuous glucose monitor data provides a new window into exactly those systemic factors.

Let’s research the connection between glucose metabolism and musculoskeletal pain, describe what a chiropractor can observe and coach with CGM data, and be clear about the referral boundaries that protect both the patient and the professional.

The Research Connection Between Metabolic Health and Musculoskeletal Pain

The relationship between metabolic dysfunction and chronic musculoskeletal pain is supported by a growing body of research.

Insulin resistance and low back pain. Studies have identified a significant association between insulin resistance and chronic low back pain. The proposed mechanisms include increased systemic inflammation, altered adipokine signaling, and changes in intervertebral disc metabolism. (Hangai M et al. Relationship between low back pain and competitive sports activities. Spine. 2010.) While this research area is still developing, the clinical implication is that a patient with persistent low back pain and visible insulin resistance patterns on a CGM trace may have a metabolic component to their pain experience that lifestyle coaching can address.

Cortisol, inflammation, and musculoskeletal symptoms. Cortisol is both a glucose-raising hormone and a primary mediator of the stress-pain connection. Chronic elevations in cortisol are associated with increased systemic inflammation, muscle tension, and pain sensitization. (McBeth J et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain. Arthritis and Rheumatism. 2007;56(1):360-371.) A chiropractor whose patient shows consistent afternoon cortisol-driven glucose elevations on a CGM trace is looking at a biomarker that is relevant to the pain and tension patterns they are treating.

Advanced glycation end products and connective tissue. Prolonged hyperglycemia leads to the formation of advanced glycation end products (AGEs), which cross-link collagen fibers and reduce connective tissue elasticity and resilience. This process has been linked to accelerated intervertebral disc degeneration and increased susceptibility to tendon and ligament injury. (Yamagishi S et al. Advanced glycation end products in aging and disease. Journal of the American Geriatrics Society. 2011.)

What Chiropractors Can Observe in CGM Data

Chiropractors practicing with CGM-wearing patients are in a position to observe patterns that are directly relevant to the clinical picture they are managing.

Chronic stress and cortisol signatures. The afternoon glucose elevation pattern driven by cortisol, described in detail in the Dawn Phenomenon and sleep disruption posts in this series, has a consistent signature on a CGM trace. A chiropractor who sees this pattern consistently in a patient's data can connect it to the chronic muscle tension and pain sensitization they are observing clinically and have an evidence-informed conversation about stress management as part of the treatment plan.

Sleep quality indicators. Poor sleep, which is associated with both increased pain perception and elevated glucose variability, often shows recognizable signatures in overnight CGM data. A chiropractor treating a patient with a condition affected by sleep quality can use CGM data as a complementary metric to monitor sleep-related recovery.

Recovery patterns after physical activity. Exercise-related glucose patterns provide information about how a patient's body responds to and recovers from physical exertion. For a chiropractor designing or recommending a rehabilitative exercise protocol, understanding the patient's metabolic response to that exercise is clinically relevant context.

What Chiropractors Coach and What They Refer

Chiropractors in private practice have a legitimate scope for lifestyle coaching that includes sleep optimization, stress management, guidance on physical activity, and general wellness education. CGM data can inform all of these conversations.

What a chiropractor does not do with CGM data is manage glucose-related medical conditions. A patient whose CGM trace suggests significant glucose dysregulation that has not been clinically evaluated should be referred to their physician. The chiropractor's role is to recognize the pattern and initiate the referral, not to diagnose or treat the metabolic condition.

The professional value of having a systematic CGM framework is that it allows the chiropractor to make this referral conversation specific: "I want your physician to look at this pattern because I've been seeing it consistently and I think it may be relevant to the progress we've been making." That is a professional referral. It is also a service to the patient that many practitioners without CGM training are not positioned to provide.

A Note on the Opportunity

Chiropractors in private practice control their own professional development decisions. They choose their continuing education, their clinical tools, and the scope of services they offer. For chiropractors who want to differentiate their practice, deepen patient relationships, and provide a level of metabolic coaching that very few manual practitioners currently offer, CGM literacy is one of the most direct paths available.

The patients are already wearing the devices. The data is already being generated. The question is whether the professional has the training to read it and the language to respond. That is precisely what the Glucose Pattern Recognition Methodology™ (GPRM™) provides.

The Certified BioFit Specialist program is open to chiropractors in private practice. Learn more at trainbiofit.com.

Sources: McBeth J et al. Moderation of psychosocial risk factors through dysfunction of the HPA stress axis in the onset of chronic widespread musculoskeletal pain. Arthritis and Rheumatism. 2007;56(1):360-371. Yamagishi S et al. Advanced glycation end products in aging and disease. Journal of the American Geriatrics Society. 2011. ADA Standards of Medical Care in Diabetes. Diabetes Care. 2024.